Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Travoprost")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 74

  • Page / 3
Export

Selection :

  • and

Mechanism of Action of Bimatoprost, Latanoprost, and Travoprost in Healthy Subjects : A Crossover StudyLIM, K. Sheng; NAU, Cherie B; O'BYRNE, Megan M et al.Ophthalmology (Rochester, MN). 2008, Vol 115, Num 5, pp 792-797, issn 0161-6420, 6 p.Article

Efficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre studyKAMMER, J. A; KATZMAN, B; ACKERMAN, S. L et al.British journal of ophthalmology. 2010, Vol 94, Num 1, pp 74-79, issn 0007-1161, 6 p.Article

The TRAVATAN Dosing Aid Accurately Records When Drops Are TakenFRIEDMAN, David S; JAMPEL, Henry D; CONGDON, Nathan G et al.American journal of ophthalmology. 2007, Vol 143, Num 4, pp 699-701, issn 0002-9394, 3 p.Article

Abdominal cramp as an adverse effect of travoprostLEE, Yuan-Chieh.American journal of ophthalmology. 2005, Vol 139, Num 1, pp 202-203, issn 0002-9394, 2 p.Article

Acute anterior uveitis and corneal edema associated with travoprostFAULKNER, William J; BURK, Scott E.Archives of ophthalmology (1960). 2003, Vol 121, Num 7, pp 1054-1055, issn 0003-9950, 2 p.Article

Thermal Stability of Bimatoprost, Latanoprost, and Travoprost Under Simulated Daily UseJOHNSON, Thomas V; GUPTA, Preeya K; VUDATHALA, Daljit K et al.Journal of ocular pharmacology and therapeutics. 2011, Vol 27, Num 1, pp 51-59, issn 1080-7683, 9 p.Article

Bimatoprost and travoprost: A review of recent studies of two new glaucoma drugsEISENBERG, Dan L; TORIS, Carol B; CAMRAS, Carl B et al.Survey of ophthalmology. 2002, Vol 47, pp S105-S115, issn 0039-6257, SUP1Article

A 6 -week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%MAUL, Eugenio; CARRASCO, Félix Gil; PAULINO COSTA, Vital et al.Clinical therapeutics. 2007, Vol 29, Num 9, pp 1915-1923, issn 0149-2918, 9 p.Article

Use of a bayesian network to predict the nighttime intraocular pressure peak from daytime measurements. CommentaryMULLINS, C. Daniel; NORDMANN, Jean-Philippe; BERDEAUX, Gilles et al.Clinical therapeutics. 2007, Vol 29, Num 8, issn 0149-2918, 1750-1760Article

Intraocular Pressure-Lowering Combination Therapies with Prostaglandin AnaloguesAPTEL, Florent; CHIQUET, Christophe; ROMANET, Jean-Paul et al.Drugs (Basel). 2012, Vol 72, Num 10, pp 1355-1371, issn 0012-6667, 17 p.Article

Intraocular Pressure Control Among Patients Transitioned From Latanoprost to Travoprost at a Veterans Affairs Medical Center Eye ClinicMCKINLEY, Steven H; SINGH, Ruhi; CHANG, Peter T et al.Journal of ocular pharmacology and therapeutics. 2009, Vol 25, Num 2, pp 153-157, issn 1080-7683, 5 p.Article

Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonistHELLBERG, Mark R; MCLAUGHLIN, Marsha A; BARNES, George et al.Survey of ophthalmology. 2002, Vol 47, pp S13-S33, issn 0039-6257, SUP1Article

Comparison of Ocular Surface Side Effects of Topical Travoprost and BimatoprostALAGÖZ, Gürsoy; BAYER, Atilla; BORAN, Cetin et al.Ophthalmologica (Basel). 2008, Vol 222, Num 3, pp 161-167, issn 0030-3755, 7 p.Article

A Comparative Study of Bimatoprost and Travoprost : Effect on Intraocular Pressure and Ocular Circulation in Newly Diagnosed Glaucoma PatientsALAGÖZ, Gürsoy; GÜREL, Kamil; BAYER, Atilla et al.Ophthalmologica (Basel). 2008, Vol 222, Num 2, pp 88-95, issn 0030-3755, 8 p.Article

Commercially Available Prostaglandin Analogs for the Reduction of Intraocular Pressure : Similarities and DifferencesBEAN, Gerald W; CAMRAS, Carl B.Survey of ophthalmology. 2008, Vol 53, issn 0039-6257, S69-S84, SUP1Article

Patients' and physicians' perceptions of the travoprost dosing aid : An open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertensionFLOWERS, Brian; WAND, Martin; PILTZ-SEYMOUR, Jody et al.Clinical therapeutics. 2006, Vol 28, Num 11, pp 1803-1811, issn 0149-2918, 9 p.Article

Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressureDUBINER, Harvey B; SIRCY, Marla D; LANDRY, Theresa et al.Clinical therapeutics. 2004, Vol 26, Num 1, pp 84-91, issn 0149-2918, 8 p.Article

Anterior uveitis is associated with travoprostKUMARASAMY, Manjula; DESAI, Shrivatsa P.BMJ. British medical journal (International ed.). 2004, Vol 329, Num 7459, issn 0959-8146, p. 205Article

TravoprostWAUGH, John; JARVIS, Blair.Drugs & aging. 2002, Vol 19, Num 6, pp 465-471, issn 1170-229X, 7 p.Article

Effects of Repeated Administrations of Tafluprost, Latanoprost, and Travoprost on Optic Nerve Head Blood Flow in Conscious Normal RabbitsAKAISHI, Takahiro; KURASHIMA, Hiroaki; ODANI-KAWABATA, Noriko et al.Journal of ocular pharmacology and therapeutics. 2010, Vol 26, Num 2, pp 181-186, issn 1080-7683, 6 p.Article

Bimatoprost Versus Travoprost in an Egyptian Population: A Hospital-Based Prospective, Randomized StudyMACKY, Tamer A.Journal of ocular pharmacology and therapeutics. 2010, Vol 26, Num 6, pp 605-610, issn 1080-7683, 6 p.Article

Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprostSTEWART, William C; KOLKER, Allan E; STEWART, Jeanette A et al.American journal of ophthalmology. 2003, Vol 135, Num 3, pp 314-320, issn 0002-9394, 7 p.Article

Prostaglandin analog treatment of glaucoma and ocular hypertensionALEXANDER, Christy L; MILLER, Sarah J; ABEL, Steven R et al.The Annals of pharmacotherapy. 2002, Vol 36, Num 3, pp 504-511, issn 1060-0280Article

Effects of corneal thickness on the intraocular penetration of travoprost 0.004%MARTINEZ-DE-LA-CASA, J. M; RAYWARD, O; SAENZ-FRANCES, F et al.Eye (London. 1987). 2012, Vol 26, Num 7, pp 972-975, issn 0950-222X, 4 p.Article

Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma PatientsSCHLOTE, Torsten; TZAMALIS, Argyrios; KYNIGOPOULOS, Myron et al.Journal of ocular pharmacology and therapeutics. 2009, Vol 25, Num 5, pp 459-462, issn 1080-7683, 4 p.Article

  • Page / 3